Cardinal Health takes $3.9bn leap into specialty healthcare with two key acquisitions

Pallavi Madhiraju- November 13, 2024 0

In a bold move to expand its reach in specialty healthcare, Cardinal Health has announced it will acquire significant assets in gastroenterology and diabetes care ... Read More

Eli Lilly completes $3.2 billion acquisition of Morphic to enhance IBD treatments

Pallavi Madhiraju- August 18, 2024 0

Eli Lilly and Company has finalised its acquisition of Morphic Holding, Inc. in a landmark $3.2 billion deal, aimed at enhancing treatment options for inflammatory ... Read More

Norgine expands presence in Germany with new office opening in Wettenberg

pharmanewsdaily- July 21, 2018 0

Dutch pharmaceutical giant Norgine has inaugurated new offices in Wettenberg, Germany, marking a significant step in its ongoing growth strategy. This move strengthens its commitment ... Read More

Takeda Pharmaceutical set to acquire TiGenix for €520m, enhancing gastroenterology and specialty care offerings

pallavi123- January 8, 2018 0

Japanese pharmaceutical giant Takeda Pharmaceutical has announced a proposal to acquire TiGenix, a Belgium-based cell therapy company, for €520 million. This acquisition is aimed at ... Read More